You could call them rebel girls themselves.
The authors behind the best-selling children’s book “Good Night Stories for Rebel Girls” are once again putting a modern spin on fairy tales with a collection of real-life female super heroes.
The book, which debuted in 2016, featured 100 stories about the lives of women, from Queen Elizabeth I to Serena Williams.
Now, “Good Night Stories for Rebel Girls Volume 2” — due out November 20 — builds on what they first started. It includes another 100 stories of female scientists, engineers, judges and painters to encourage young girls to grow up to be and do whatever they choose.
Among those featured are teenage eagle hunter Aisholpan Nurgaiv; the NASA women who inspired the film “Hidden Figures” (Katherine Johnson, Dorothy Vaughan and Mary Jackson); and “Frankenstein” author Mary Shelley.
The stories come from all over the world, including China, North Korea and the Sudan.
Like with the first book, all visuals are drawn by female illustrators.
what is share market: Alere Inc.(ALR)
- [By Lisa Levin]
In trading on Wednesday, healthcare shares fell by 0.91 percent. Meanwhile, top losers in the sector included Alere Inc (NYSE: ALR), down 8 percent, and Exelixis, Inc. (NASDAQ: EXEL), down 10 percent.
- [By Lisa Levin]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.
what is share market: Caterpillar, Inc.(CAT)
- [By Ben Levisohn]
And while big gains from likes of Caterpillar (CAT) weren’t enough to push the S&P 500 over 2,400, that could change soon, write JPMorgan’s Jason Hunter and Alix Tepper. They explain why:
- [By Chris Dier-Scalise]
The IMX report also highlighted a sell-off among their clients in companies that experienced some friction during the month. Caterpillar Inc. (NYSE: CAT) was net sold as federal investigators continued their probe into the construction equipment company's export filings. Starbucks Corporation (NASDAQ: SBUX) was net sold as former CEO Howard Schultz prepared for his departure from the company in April.
- [By Paul Ausick]
The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was Caterpillar Inc. (NYSE: CAT) which traded up 2.10% at $94.21. The stock’s 52-week range is $69.04 to $99.46. Volume was about 20% below the daily average of around 5.2 million. The company was upgraded to Goldman Sachs’ Conviction Buy list this morning.
- [By Ben Levisohn]
Things were looking up for Caterpillar (CAT)–and then the Fed’s came a knockin’.
Agence France-Presse/Getty Images
Shares of Caterpillar had returned 7.1 percent so far this year–and 47% over the last 12 months–as optimism about the state of the global economy pushed its shares higher. But Caterpillar’s shares are tumbling this afternoon after reports that its offices in Peoria, Ill. and elsewhere were raided by Federal officers today.
The Wall Street Journal’s Andrew Tangel reports:
Agents from the Internal Revenue Service, the Federal Deposit Insurance Corp. and the U.S. Department of Commerce participated in the searches, according to a spokeswoman for the U.S. attorneys office for the Central District of Illinois.
The U.S. attorneys spokeswoman said agents were at Caterpillar locations in Peoria, East Peoria and Morton, Ill. No arrests were made, the spokeswoman said.
What are they investigating? No one seems to know as of yet, but I’m sure we will soon.
Shares of Caterpillar have dropped 4.8% to $93.85 at 2:03 p.m. today.
what is share market: Warren Resources Inc.(WRES)
- [By Lisa Levin]
Shares of Warren Resources, Inc. (NASDAQ: WRES) were down 31 percent to $0.0656. Warren Resources filed for Chapter 11 bankruptcy.
Gogo Inc (NASDAQ: GOGO) was down, falling around 15 percent to $9.40 after the company announced it has reached an agreement with American Airlines Group Inc (NASDAQ: AAL) to “continue to provide service on a meaningful portion of the American fleet currently served by Gogo.” Investors heavily sold off the stock as the company’s announcement implies it lost some orders to its main competitor, ViaSat, Inc. (NASDAQ: VSAT).
what is share market: Two Harbors Investments Corp(TWO)
- [By David Hanson]
This week at the Barclays Capital Global Financials Conference, droves of CEOs, CFOs, and CIOs trotted on stage to address a room full of eager analysts. One of the lone mREITs represented was Two Harbors (NYSE: TWO ) . CEO Tom Siering and CIO Bill Roth weighed in on the current environment.
what is share market: 8×8 Inc(EGHT)
- [By Anders Bylund]
Shares of 8×8 (NASDAQ:EGHT) rose 26.6% in 2016, according to data from S&P Global Market Intelligence.
The provider of internet-based voice and communications services put together a remarkable financial record last year. 8X8 beat Wall Street’s earnings and sales estimates handily in each one of the year’s quarterly reports,citing strong organic revenue growth among larger customers along the way. Large-scale corporate customers accounted for 53% of the company’s total sales in the recently reported second quarter, and these big clients are also showing strong loyalty to the 8×8 brand by renewing their service contracts.
- [By Lisa Levin]
Telecommunications services shares climbed 0.56 percent in trading on Thursday. Meanwhile, top gainers in the sector included Frontier Communications Corp (NASDAQ: FTR), and 8×8, Inc. (NASDAQ: EGHT).
- [By Peter Graham]
A long term performance chart shows small cap magicJack VocalTec Ltd underperforming versus VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) which have been volatile, but have been heading higher:
- [By Peter Graham]
A long term performance chart shows small cap magicJack VocalTec Ltd hitting lower highs and lowerlows for some years now but also leveling off while VOIP related peers Vonage Holdings Corp (NYSE: VG)and 8×8, Inc (NASDAQ: EGHT) have been volatile, but also largely heading higher:
what is share market: Lexaria Bioscience (LXRP)
- [By James E. Brumley]
Don’t be surprised if Lexaria Bioscience Corp (OTCMKTS:LXRP) shares seem a little peppier and even more bullish than usual for the next three months, give or take… and that’s saying something considering LXRP is 158% since early October, and up 47% since mid-December. Why’s that? The organization has hired a publicity firm to help tell its story to an even bigger audience, and that attention could attract a whole new batch of buyers for the stock.
Granted, the Lexaria Bioscience story is a compelling one to begin with.
If 2016 (and 2017 so far) were to be pegged with any major investment “themes,” cannabis would have to be it. Marijuana/hemp — cannabinoids, ultimately — was on the ballot for one reason or another in nine states this past November, and those pro-cannabis measures passed in eight of those votes. As such, cannabis is now legal for at least one reason in 26 states of the United States, and the movement is still gathering momentum.
And well it should. The recreational aspect of marijuana and cannabinoids aside, hemp (a form of cannabis plant that isn’t the kind of marijuana that provides a “high”) delivers a multitude of health benefits. Specifically, users of hemp oil find the plant-based oil improves immunity, improves cardiovascular health, moderates blood sugar, treats skin conditions, treats arthritis, inhibits osteoporosis, fights some mental disorders, and in some cases has been found to be an anti-cancer agent. Lexaria Bioscience is simply enhancing these benefits of hemp oil by enhancing the amount of hemp oil a human body can absorb when ingested.
Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. The key to the science is the fact that Lexaria Bioscience is able to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is it
- [By Bryan Murphy]
In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.
The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.
That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.
The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.
Lexaria Bioscience changes this. In short,
- [By Jim Robertson]
Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed:
- [By James E. Brumley]
Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.
The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).
Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”
In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.
The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.
Hemp seeds (which are technically a nut and are als
- [By Matthew Briar]
Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.
The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.
Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.
More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe